Stifel lowered the firm’s price target on Astrana Health (ASTH) to $56 from $70 and keeps a Buy rating on the shares ahead of Astrana reporting ...

Stifel Nicolaus analyst Michael Craig Jones maintained a Buy rating on Astrana Health (ASTH – Research Report) today and set a price target of ...

Diamond Hill Capital, an investment management company, released its “Small Cap Fund” fourth-quarter 2024 investor letter. A ...

About Astrana Health, Inc. Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the company, Marketbeat Ratings reports.

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like ...

This page features the latest news about the Astrana Health stock. Apollo Medical Holdings, Inc. Tops Q3 EPS by 12c Apollo Medical Holdings, Inc. (AMEH) reported Q3 EPS of $0.56, $0.12 better than ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...